Predictive Oncology Inc. - Common Stock (POAI)
1.5100
+0.0100 (0.67%)
Predictive Oncology Inc is a healthcare technology company focused on advancing personalized medicine through the use of artificial intelligence and machine learning
The company leverages a proprietary platform to analyze and model cancer treatment responses, aiming to provide insights that optimize therapeutic strategies for individual patients. By integrating extensive genomic and clinical data, Predictive Oncology seeks to improve patient outcomes and reduce the time and costs associated with drug development, ultimately enhancing the effectiveness of cancer therapies. Their innovative approach positions them at the forefront of cancer research, contributing to the development of more effective and tailored treatment options.
Frequently Asked Questions
Is Predictive Oncology Inc. - Common Stock publicly traded?
Yes, Predictive Oncology Inc. - Common Stock is publicly traded.
What exchange does Predictive Oncology Inc. - Common Stock trade on?
Predictive Oncology Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Predictive Oncology Inc. - Common Stock?
The ticker symbol for Predictive Oncology Inc. - Common Stock is POAI on the Nasdaq Stock Market
What is the current price of Predictive Oncology Inc. - Common Stock?
The current price of Predictive Oncology Inc. - Common Stock is 1.510
When was Predictive Oncology Inc. - Common Stock last traded?
The last trade of Predictive Oncology Inc. - Common Stock was at 1:40 pm EST on February 5th, 2025
What is the market capitalization of Predictive Oncology Inc. - Common Stock?
The market capitalization of Predictive Oncology Inc. - Common Stock is 6.14M
How many shares of Predictive Oncology Inc. - Common Stock are outstanding?
Predictive Oncology Inc. - Common Stock has 4.06M shares outstanding.